Form D · Biotechnology

ENRICH BIOSYSTEMS INC.

Branford, CT · CIK 0001931770

Offering snapshot reported Nov 26, 2025 · SEC filing

Reported sold
$1.45M
Offering amount: $1.5M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 13, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 26, 2025Initial$1,450,000No comparison4SEC filing
May 20, 2024Initial$2,241,765No comparison17SEC filing
May 20, 2024Initial$750,000No comparison10SEC filing
Jun 3, 2022Initial$3,775,000No comparison26SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-565138

Source: Form D, filed Nov 26, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cynthia Green Director
Christopher Mc Leod Director
Jay Teich Director
Daniel Wagner Director
Dong Wang Director, Executive
Qi Zhao Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
21 Business Park Drive, Suite 4
Branford, CT, 06405